Michael J. Cavnar - Concepedia

Author

Michael J. Cavnar

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

Cavnar, Michael, Cavnar, Michael J., M J Cavnar, M. Cavnar, M.J. Cavnar, Micha Cavnar, Michael Cavnar, Michael J Cavnar, Michael J. Cavnar, Michael J. Cavnar, MD

116

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center University of Kentucky University of Toronto Health Sciences Centre Cornell University

About

Michael J. Cavnar is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	1.1K
2	Cell Biology	4	4	188
3	Health Sciences	3	3	54
4	Engineering	2	2	52
5	Natural Sciences	1	1	19

Michael J. Cavnar

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido Vinod P. Balachandran, Michael J. Cavnar, Shan Zeng, Nature Medicine Cancer ImmunosurveillanceGastrointestinal OncologyMedicineT-regulatory CellImmunology	2011	517
KIT oncogene inhibition drives intratumoral macrophage M2 polarization Michael J. Cavnar, Shan Zeng, Teresa S. Kim, The Journal of Experimental Medicine Cancer ResearchTumor-associated MacrophagesOncogenic AgentMedicineTumor Growth	2013	126
Outcome of 1000 Patients With Gastrointestinal Stromal Tumor (GIST) Treated by Surgery in the Pre- and Post-imatinib Eras Michael J. Cavnar, Kenneth Seier, Christina Curtin, Annals of Surgery Surgical OncologyPost-imatinib ErasPrognosisCancer ManagementGastroenterology	2019	92
Neutrophil IL-10 suppresses peritoneal inflammatory monocytes during polymicrobial sepsis Lee M. Ocuin, Zubin M. Bamboat, Vinod P. Balachandran, Journal of Leukocyte Biology	2010	87
Rectal Gastrointestinal Stromal Tumor (GIST) in the Era of Imatinib: Organ Preservation and Improved Oncologic Outcome Michael J. Cavnar, Lin Wang, Vinod P. Balachandran, Annals of Surgical Oncology Surgical OncologyGastrointestinal OncologyColorectal SurgeryMedicineGastroenterology	2017	81
Blood Neutrophil-to-Lymphocyte Ratio is Prognostic in Gastrointestinal Stromal Tumor Daniel Pérez, Raymond E. Baser, Michael J. Cavnar, Annals of Surgical Oncology Gastrointestinal OncologyMedicineMalignant Blood DisorderImmunologyHematology	2012	70
Tumor-Associated Macrophage Infiltration in Colorectal Cancer Liver Metastases is Associated With Better Outcome Michael J. Cavnar, Simon Turcotte, Steven C. Katz, Annals of Surgical Oncology Tumor BiologyHepatologyMedicineLiver PhysiologyImmunology	2017	67
Nilotinib protects the murine liver from ischemia/reperfusion injury Lee M. Ocuin, Shan Zeng, Michael J. Cavnar, Journal of Hepatology	2012	52
Increased KIT Inhibition Enhances Therapeutic Efficacy in Gastrointestinal Stromal Tumor Teresa S. Kim, Michael J. Cavnar, Noah A. Cohen, Clinical Cancer Research	2014	52
Wnt/β-catenin Signaling Contributes to Tumor Malignancy and Is Targetable in Gastrointestinal Stromal Tumor Shan Zeng, Adrian M. Seifert, Jennifer Q. Zhang, Molecular Cancer Therapeutics	2017	39

Page 1